AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DOXORUBICIN HYDROCHLORIDE
54 registrations across 9 African markets— 42 active
Markets with DOXORUBICIN HYDROCHLORIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ADRIB 50mg/25ml Solution For Infusion | 🇰🇪Kenya | M/S BETA DRUGS PVT. LTD | active | Jul 2031 |
| CAELYX PEGYLATED LIPOSOMAL CONCENTRATE FOR SOLUTION FOR INFUSION (Each ml contains Doxorubicin Hydrochloride 20mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| CAELYX PEGYLATED LIPOSOMAL CONCENTRATE FOR SOLUTION FOR INFUSION (Each ml contains Doxorubicin Hydrochloride 20mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| Doxorubicin Sandoz solution for infusion Solution for Injection | 🇿🇲Zambia | Sandoz SA (PTY) LTD | active | Jul 2030 |
| Oncodox 50 injection Powder for Injection | 🇿🇲Zambia | Cipla Ltd | active | Dec 2029 |
| DOXRED 10 LYOPHILIZED POWDER | 🇿🇦South Africa | Oethmaan Biosims (Pty) Ltd | active | Feb 2029 |
| DOXRED 50 LYOPHILIZED POWDER | 🇿🇦South Africa | Oethmaan Biosims (Pty) Ltd | active | Feb 2029 |
| Caelyx Injection** Solution for injection | 🇳🇬Nigeria | PharmaSymbiosis Limited | active | Nov 2028 |
| ADRIB 50mg/25ml Solution For Infusion | 🇰🇪Kenya | M/S BETA DRUGS PVT. LTD | active | Jun 2028 |
| NAPRODOX 50 SOLUTION; INJECTION | 🇿🇼Zimbabwe | NAPROD LIFE SCIENCES PVT LTD | active | Dec 2027 |
| NAPRODOX 10 SOLUTION; INJECTION | 🇿🇼Zimbabwe | NAPROD LIFE SCIENCES PVT LTD | active | Dec 2027 |
| ROBOL -50 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | VENUS REMEDIES LTD | active | Dec 2027 |
| I-DOX 20mg/10ml Injection | 🇰🇪Kenya | GETWELL PHARMACEUTICALS LTD | active | Jan 2027 |
| DOXORUBICIN SANDOZ SOLUTION INFUSION ( Doxorubicin Hydrochloride 200mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| DOXORUBICIN SANDOZ SOLUTION INFUSION ( Doxorubicin Hydrochloride 200mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| I-DOX 50mg/25ml Injection | 🇰🇪Kenya | GETWELL PHARMACEUTICALS LTD | active | Sept 2026 |
| ADRIBLASTINA 50MG/5ML INJECTION (Each 5ml contains Doxorubicin Hydrochloride 50mg) | 🇬🇭Ghana | PFIZER SPECIALITIES LIMITESD 7TH FLOOR 21 LUGGARD V IKOYI LAGOS NIGERIA | active | Sept 2026 |
| ADRIBLASTINA 10MG/5ML INJECTION (Each 5ml contains Doxorubicin Hydrochloride 10mg) | 🇬🇭Ghana | PFIZER SPECIALITIES LIMITESD 7TH FLOOR 21 LUGGARD V IKOYI LAGOS NIGERIA | expired | Sept 2026 |
| ADRIBLASTINA 10MG/5ML INJECTION (Each 5ml contains Doxorubicin Hydrochloride 10mg) | 🇬🇭Ghana | PFIZER SPECIALITIES LIMITESD 7TH FLOOR 21 LUGGARD V IKOYI LAGOS NIGERIA | active | Sept 2026 |
| ADRIBLASTINA 10MG/5ML INJECTION (Each 5ml contains Doxorubicin Hydrochloride 10mg) | 🇬🇭Ghana | PFIZER SPECIALITIES LIMITESD 7TH FLOOR 21 LUGGARD V IKOYI LAGOS NIGERIA | active | Sept 2026 |
| ADRIBLASTINA 50MG/5ML INJECTION (Each 5ml contains Doxorubicin Hydrochloride 50mg) | 🇬🇭Ghana | PFIZER SPECIALITIES LIMITESD 7TH FLOOR 21 LUGGARD V IKOYI LAGOS NIGERIA | active | Sept 2026 |
| ADRIBLASTINA 50MG/5ML INJECTION (Each 5ml contains Doxorubicin Hydrochloride 50mg) | 🇬🇭Ghana | PFIZER SPECIALITIES LIMITESD 7TH FLOOR 21 LUGGARD V IKOYI LAGOS NIGERIA | expired | Sept 2026 |
| Adriblastina CS 10 mg/5 mL Injection** Solution for injection | 🇳🇬Nigeria | Pfizer Specialties Ltd | active | Jun 2026 |
| Adriblastina CS 50 mg/25 mL Injection** Solution for injection | 🇳🇬Nigeria | Pfizer Specialties Ltd | active | Jun 2026 |
| ONCODOXIN 50MG/25ML SOLUTION SOLUTION | 🇲🇼Malawi | — | expired | Mar 2024 |
| ADRIBLASTINA RD 50 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Feb 2024 |
| ADRIBLASTINA CSV 10 mg/5 ml | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Feb 2024 |
| ADRIBLASTINA RD 20 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Feb 2024 |
| ADRIBLASTINA CSV 50 mg/25 ml | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Feb 2024 |
| ADRIBLASTINA RD 10 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Feb 2024 |
| DOXORUBICIN HCL-FAULDING 10 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Feb 2024 |
| DOXORUBICIN HCL-FAULDING 50 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Feb 2024 |
| DOXORUBICIN "EBEWE" 50 mg | 🇿🇦South Africa | Key Oncologics (Pty) Ltd | suspended | Jul 2022 |
| DOXORUBICIN "EBEWE" 10 mg | 🇿🇦South Africa | Key Oncologics (Pty) Ltd | suspended | Jul 2022 |
| BIO-DOXORUBICIN HYDROCHLORIDE 10 | 🇿🇦South Africa | Zimbili Pharma cc | active | Oct 2006 |
| BIO-DOXORUBICIN HYDROCHLORIDE 50 | 🇿🇦South Africa | Zimbili Pharma cc | active | Jan 1900 |
| RUBEXET 200 mg/100 ml | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| DOXOPEG | 🇿🇦South Africa | Key Oncologics (Pty) Ltd | active | Jan 1900 |
| CIPLA-DOXORUBICIN 50 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| RUBEXET 50 mg/25 ml | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| CAELYX | 🇿🇦South Africa | Baxter Healthcare South Africa (Pty) Ltd | active | Jan 1900 |
| HX-DOXORUBICIN 50 mg/ 25 ML | 🇿🇦South Africa | Oethmaan Biosims (Pty) Ltd | active | Jan 1900 |
| CIPLA-DOXORUBICIN 10 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| DOXORUBICIN ACCORD 50 mg/25 ml | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| RUBEXET 10 mg/5 ml | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | active | Jan 1900 |
| DOXORUBICIN-SOL PCH 10 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| DOXORUBICIN-SOL PCH 50 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| DOXORUBICIN-SOL PCH 200 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| HX-DOXORUBICIN 10 mg/ 5 ml | 🇿🇦South Africa | Oethmaan Biosims (Pty) Ltd | active | Jan 1900 |
| ONCODOX-10 PDRE LYOPH PPI BTE FL(15ML) CIPLA HOUSE poudre lyophilisée pour | 🇲🇬Madagascar | CIPLA LTD. | active | — |
Showing 50 of 54 registrations. Sign up free to search and export all.
DOXORUBICIN HYDROCHLORIDE in Africa — Regulatory Overview
DOXORUBICIN HYDROCHLORIDE is registered across 9 African markets with 54 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Kenya, Madagascar and 5 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 54 registrations, 42 (78%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.